CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.
May 8th 2024
The Food and Drug Administration granted a Biologics License Application for subcutaneous Opdivo for potential approval.
FDA Approves Two New Indications for Keytruda in Advanced Melanoma
December 18th 2015The FDA has expanded the approval for single-agent Keytruda to include the frontline treatment of patients with advanced melanoma regardless of BRAF status and to include the treatment of patients with Yervoy-refractory melanoma.
Odomzo, a New Treatment for Basal Cell Carcinoma, Approved by FDA
August 5th 2015The U.S. Food & Drug Administration has approved Odomzo (sonidegib) for the treatment of patients with locally advanced basal cell carcinoma who have experienced a recurrence of this condition after surgery or radiation, or who weren't eligible for those therapies.